LWM
TMO icon

LeConte Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

LeConte Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Buy
456
+7
+2% +$3.36K 0.12% 138
2026
Q1 		$221K Buy
449
+25
+6% +$13.6K 0.14% 132
2025
Q4 		$246K Sell
424
-35
-8% -$19.8K 0.16% 102
2025
Q3 		$223K Buy
+459
New +$214K 0.15% 115

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LeConte Wealth Management's TMO Position: Q2 2026 in Review

LeConte Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 1.6% in Q2 2026, buying an estimated $3.36K and bringing the position to 456 shares worth $229K. The position accounts for 0.12% of the portfolio, ranked #138.

LeConte Wealth Management first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. The position peaked at $246K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LeConte Wealth Management held 456 shares of Thermo Fisher Scientific worth $229K as of Q2 2026.
  • LeConte Wealth Management bought 7 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.36K.
  • Thermo Fisher Scientific made up 0.12% of LeConte Wealth Management's portfolio in Q2 2026, its #138 holding.
  • LeConte Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • LeConte Wealth Management's Thermo Fisher Scientific position peaked at $246K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LeConte Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.